Now Recruiting: Clinical Study of ACEND™ for Joint Health and Osteoarthritis Relief
BiomeMimetics is enrolling participants for a 3-month clinical study evaluating ACEND™, a novel medical food designed for the dietary management of chronic inflammation in adults with early-stage osteoarthritis. Individuals aged 40–60 experiencing joint pain, stiffness, swelling, or tenderness may be eligible. The study involves taking ACEND™ twice daily and tracking outcomes through a daily survey using a personalized health app. This research supports our commitment to advancing microbiome-targeted solutions for inflammatory conditions.
Learn more and check your eligibility:
Learn more and check your eligibility:
Now Recruiting: Now Recruiting: Clinical Study of ACEND™ for Glucose Control in Pre-Diabetes BiomeMimetics is conducting a 4-month clinical study evaluating ACEND™, a microbiome- focused medical food developed to support glucose homeostasis through the dietary management of metabolism and inflammation.
The study is enrolling adults aged 40–60 with a diagnosis of pre-diabetes—including those with elevated fasting glucose, impaired glucose tolerance, or increased HbA1c who are not currently on diabetes medication or enrolled in a weight loss program. Participants will take ACEND™ twice daily, track their experience through a personalized health app, and contribute to research exploring the connection between gut health, metabolic regulation, and chronic inflammation.
Learn more and check your eligibility:
Learn more and check your eligibility: